Concepedia

Ching-Man Virbasius

CV

Statistics

Publications

8

Citations

883

H-Index

8

Active since

1996

Affiliations

Howard Hughes Medical Institute(Current)

University of Massachusetts Chan Medical School

Genopole (France)

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Université Paris Cité

Ching-Man Virbasius is an author at Howard Hughes Medical Institute specializing in molecular biology, life sciences, and epigenetic regulation in cancer.

Publications per year

1996–2018

8

Publications

8

An elaborate pathway required for Ras-mediated epigenetic silencing

Claude Gazin, Narendra Wajapeyee, Stéphane Gobeil et al. · Nature · 2007 · 276 citations

, , +14

TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein

Sanchita Bhatnagar, Claude Gazin, Lynn Chamberlain et al. · Nature · 2014 · 184 citations

, , +11

Yeast TAF(II)90 is required for cell-cycle progression through G2/M but not for general transcription activation.

Lynne Apone, Ching-Man Virbasius, Joseph C. Reese et al. · Genes & Development · 1996 · 140 citations · Full text

, , +17

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation

Sung Mi Park, Jianhong Ou, Lynn Chamberlain et al. · Molecular Cell · 2016 · 129 citations · Full text

, , +13

MEN1 Is a Melanoma Tumor Suppressor That Preserves Genomic Integrity by Stimulating Transcription of Genes That Promote Homologous Recombination-Directed DNA Repair

Minggang Fang, Fen Xia, Meera Mahalingam et al. · Molecular and Cellular Biology · 2013 · 53 citations · Full text

, , +17

1–5 of 8